Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer

OBJECTIVES: A small subset of patients treated with immune checkpoint inhibitors manifest atypical patterns of response, the so-called pseudoprogression (PP) and hyperprogression (HP). Their prevalence in urothelial (UC) and renal cancer (RCC) remains, to date, mostly uninvestigated. Therefore, we a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :World J Urol
Главные авторы: Soria, Francesco, Beleni, Andrea I., D’Andrea, David, Resch, Irene, Gust, Kilian M., Gontero, Paolo, Shariat, Shahrokh F.
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2018
Предметы:
Topic Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208670/
https://ncbi.nlm.nih.gov/pubmed/29549485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00345-018-2264-0
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы